Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Genetown crawled time : 15:00 save search
Syros Announces Completion of Enrollment of 190 Patients Necessary to Support Primary Endpoint Analysis in SELECT-MDS-1 Phase 3 Trial
Published: 2024-03-25 (Crawled : 15:00) - biospace.com/
SYRS | $4.69 -0.64% 19K
|
Health Technology
|
| O: -0.32%
H: 3.84%
C: 2.4%
trial
Thermo Fisher Scientific Launches CorEvitas Clinical Registry in Generalized Pustular Psoriasis
Published: 2024-03-08 (Crawled : 15:00) - biospace.com/
TMO | News | $543.03 0.28% 300K
|
Health Technology
|
| O: -0.11%
H: 1.14%
C: 0.1%
psoriasis registry
PureTech to Present at Two Upcoming Investor Conferences - February 27, 2024
Published: 2024-02-27 (Crawled : 15:00) - biospace.com/
PTCHF | $2.78 19.97% 560
|
n/a
|
| O: -0.56%
H: 0.0%
C: -0.38%
Arkuda Therapeutics Announces Option and Asset Purchase Agreement
Published: 2024-02-07 (Crawled : 15:00) - biospace.com/
JNJ | News | $146.39 0.45% 1.8M
|
Health Technology
|
| O: 1.47%
H: 0.0%
C: 0.0%
LLY | $731.1 -1.99% 1M
|
Health Technology
|
| O: 0.76%
H: 4.31%
C: 2.11%
therapeutics agreement
Scholar Rock Presents New Preclinical Data Demonstrating Potential Benefit of SRK-439 for Healthy Weight Loss Management
Published: 2024-02-06 (Crawled : 15:00) - biospace.com/
SRRK A | $13.94 -0.07% 130K
|
Health Technology
|
| O: 1.11%
H: 7.05%
C: 3.3%
srk-439 management preclinical rock potential
Inozyme Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - February 6, 2024
Published: 2024-02-06 (Crawled : 15:00) - biospace.com/
INZY | $4.485 -2.07% 88K
|
Health Technology
|
| O: 0.0%
H: 2.45%
C: 2.08%
pharma nasdaq grants
Charles River Introduces the First Rapid Animal-Free Bacterial Endotoxin Test
Published: 2024-01-29 (Crawled : 15:00) - biospace.com/
CRL | $228.6 0.46% 62K
|
Commercial Services
|
| O: -0.4%
H: 2.63%
C: 2.35%
first test rapid
Seres Therapeutics to Participate in the Piper Sandler 35th Annual Healthcare Conference on Wednesday, November 29, 2023; Webcast at 3:30 p.m. ET
Published: 2023-11-28 (Crawled : 15:00) - biospace.com/
MCRB | $0.5845 0.05% 1.2M
|
Health Technology
|
| O: -2.59%
H: 2.65%
C: 0.0%
conference therapeutics
Sarepta Therapeutics to Present at the UBS Biopharma Conference
Published: 2023-11-02 (Crawled : 15:00) - biospace.com/
SRPT | $115.845 -0.61% 120K
|
Health Technology
|
| O: 3.8%
H: 3.51%
C: -2.1%
conference biopharma therapeutics
Scholar Rock to Participate in Upcoming Investor Conferences - November 2, 2023
Published: 2023-11-02 (Crawled : 15:00) - biospace.com/
SRRK A | $13.94 -0.07% 130K
|
Health Technology
|
| O: 0.0%
H: 2.28%
C: 1.95%
rock
Amylyx Pharmaceuticals to Report Third Quarter 2023 Financial Results on November 9, 2023
Published: 2023-11-02 (Crawled : 15:00) - biospace.com/
AMLX | $1.985 0.25% 270K
|
|
| O: 2.63%
H: 5.21%
C: 2.68%
report pharmaceuticals financial results
Vertex to Present New Data on Exagamglogene Autotemcel (exa-cel) at the American Society of Hematology (ASH) Annual Meeting and Exposition
Published: 2023-11-02 (Crawled : 15:00) - biospace.com/
VRTX | News | $395.42 0.49% 290K
|
Health Technology
|
| O: 0.24%
H: 1.79%
C: 1.71%
meeting
Curis Provides Third Quarter 2023 Business Update
Published: 2023-11-02 (Crawled : 15:00) - biospace.com/
CRIS | $15.12 -0.66% 1.4K
|
Health Technology
|
| O: -5.73%
H: 9.46%
C: 1.58%
business update
Takeda Announces Approval of CUVITRU™ Subcutaneous Immunoglobulin in Japan for Patients with Agammaglobulinemia or Hypogammaglobulinemia
Published: 2023-09-25 (Crawled : 15:00) - biospace.com/
TAK | News | $13.255 0.72% 200K
|
Health Technology
|
| O: 0.57%
H: 0.38%
C: 0.25%
japan approval
Pressure BioSciences’ Partner Veterans Service Team Increases Existing Purchase Order by 10X for Bottles of UltraShear Nano-CBD Topical Spray, Effective Immediately
Published: 2023-09-22 (Crawled : 15:00) - biospace.com/
PBIO | $0.2697 37K
|
Health Technology
|
| O: 2.63%
H: 2.56%
C: 2.56%
service order
Vertex Receives CHMP Positive Opinion for KAFTRIO® (ivacaftor/tezacaftor/elexacaftor) in Combination With Ivacaftor for Children With Cystic Fibrosis Ages 2 Through 5
Published: 2023-09-15 (Crawled : 15:00) - biospace.com/
VRTX | News | $395.42 0.49% 290K
|
Health Technology
|
| O: 0.53%
H: 0.42%
C: -0.67%
kaftrio chmp children positive fibrosis
Lyndra Therapeutics Doses First Clinical Trial Participant in Pivotal Study of Oral Weekly Risperidone (LYN-005) for Schizophrenia and Schizoaffective Disorder
Published: 2023-05-09 (Crawled : 15:00) - biospace.com/
FNCTF | News | $11.0354 320
|
Communications
|
| O: -0.66%
H: 0.0%
C: 0.0%
GILD | News | $66.495 0.51% 1.9M
|
Health Technology
|
| O: -0.36%
H: 1.23%
C: 0.63%
lyn-005 schizophrenia trial therapeutics study
Extended Consumer Testing Strongly Validates Market Transforming Speed and Dosing Efficiency of Pressure BioSciences UltraShear Processed Nano-THC Oral Spray
Published: 2023-05-09 (Crawled : 15:00) - biospace.com/
PBIO | $0.2697 37K
|
Health Technology
|
| O: 0.0%
H: 13.64%
C: 13.64%
spray market
ELAHERE® Demonstrates Overall Survival Benefit in the Phase 3 MIRASOL Trial in Patients with FRα-Positive Platinum-Resistant Ovarian Cancer
Published: 2023-05-03 (Crawled : 15:00) - biospace.com/
IMGN | $31.23 0.03% 49M
|
Health Technology
|
| O: 103.65%
H: 25.66%
C: 15.77%
elahere cancer trial
Editas Medicine Receives FDA Orphan Drug Designation for EDIT-301 for the Treatment of Sickle Cell Disease
Published: 2023-04-27 (Crawled : 15:00) - biospace.com/
EDIT | $5.51 -0.72% 490K
|
Health Technology
|
| O: 0.89%
H: 5.9%
C: 0.63%
edit-301 fda drug disease cell treatment designation
Gainers vs Losers
| 79% | 21% |
Top 10 Gainers
AGBA | News | $1.22 205.0% 86M
|
Finance
EGOX | $0.0606 68.33% 250M
|
NVFY | $3.45 63.51% 20M
|
Consumer Durables
ZCMD | $1.98 36.55% 27M
|
Commercial Services
CHRO | $1.66 35.51% 70K
|
n/a
INDO | $5.43 33.09% 10M
|
Energy Minerals
PAPL | $2.07 26.22% 550K
|
RWOD | $10.08 26.05% 5.6M
|
n/a
AULT | $0.304 25.57% 47M
|
Manufacturing
HUSA 4 | $2.07 23.95% 2.1M
|
Energy Minerals
Your saved searches
Save your searches and get alerts when important news are released.